By Troy Closson
[Want to get New York Today by email? Here’s the sign-up.]
Weather: Mix of sun and clouds, and windy. High in the mid-60s.
Alternate-side parking: In effect today. Suspended tomorrow for Solemnity of the Ascension and Eid al-Fitr.
Some New York families will soon be able to take another step toward normalcy.
This week, the Food and Drug Administration authorized use of the Pfizer-BioNTech coronavirus vaccine for 12- to 15-year-olds. It is not the last hurdle: A federal advisory committee must meet to make recommendations for the vaccine’s use in the age group, and a state task force oversees the final approval.
But Gov. Andrew M. Cuomo said this week that vaccinations are set to be cleared for 12- to 15-year-olds as soon as tomorrow.
Here’s what you need to know:
What do the studies show?
Clinical trials have found that children in the age group may safely receive the dose already available for adults, and indicate that it is highly effective at preventing symptomatic illness.
The side effects for the children involved in the trials were comparable to those seen in trial participants who were 16 to 25 years old, my colleague Apoorva Mandavilli reported. Scientists also agreed that the Pfizer-BioNTech vaccine seemed to meet all expectations regarding safety and efficacy.
The vaccine is already available to anyone 16 or over. Mr. Cuomo said that across the state, the focus would remain on increasing vaccinations among people 16 to 40 years old.
[Read more about the findings.]
What about children under 12?
Pfizer and BioNTech have begun testing the vaccine in children ages 2 to 11. If trial results are positive, the companies expect to apply to the F.D.A. in September for emergency authorization to administer doses to those age groups.
Source: Read Full Article